Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond

Purpose: Radiotherapy is integral in the management of hematological malignancies (HM). Standard radiotherapy dose fractionation regimens range between 20 and 50 Gy in 10–25 fractions over 2–5 weeks. This study presents the outcomes of patients with HM treated with hypofractionation radiotherapy (HF...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Febin Antony, Arbind Dubey, Pamela Skrabek, Lung Fung Tsang, Pascal Lambert, Bohdan Bybel, Naseer Ahmed
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-01-01
Sarja:	Current Oncology
Aiheet:	lymphomas hypofractionation radiotherapy
Linkit:	https://www.mdpi.com/1718-7729/31/1/25
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!